You are here

Article Text

Article menu
Download PDFPDF
Case report
Subcutaneous lacosamide for seizures
  1. Natalie McCarthy,
  2. Elizabeth Freshwater and
  3. Nial McCarron
  1. Medical, Myton Hospices, Warwick, UK
  1. Correspondence to Dr Elizabeth Freshwater; elizabeth.freshwater{at}nhs.net

Abstract

The management of seizures at the end of life is vital for patient comfort and to reduce carer distress. The use of high -dose subcutaneous benzodiazepines is standard, but not always effective. We present a case where lacosamide was used subcutaneously to prevent seizure activity.

  • Seizures
  • Drug administration
  • Pharmacology
  • Terminal care

https://doi.org/10.1136/spcare-2023-004699

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors All authors contributed to the care of the patient, the inception of the case review and agreed the final version. NatMcC and EF drafted the initial version. EF obtained consent from the next of kin.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.